Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs
media
posted on 2021-06-17, 13:51 authored by Adis Rapid Journals on behalf of:, Euphemia Leung, Jinal Patel, Jennifer A. Hollywood, Ayesha Zafar, Petr Tomek, David Barker, Lisa I. Pilkington, Michelle van Rensburg, Ries J. Langley, Nuala A. Helsby, Christopher J. Squire, Bruce C. Baguley, William A. Denny, Jóhannes Reynisson, Ivanhoe K. H. Leung<p><strong>Article full
text</strong></p>
<p><br>
The above summary slide represents the opinions of
the <b>authors</b>. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC <b>2021</b>.<b>
</b></p>
History
Related Materials
- 1.
- 2.
